The prescription dermatology therapeutics market witnessed a significant growth rate owing to high incidence and an increase in the prevalence rate of infectious and chronic dermatological disorders, and novel drug development across the world. Skin is the largest and most exposed organ body part to a wide variety of toxins and microbes. Lengthy exposure of skin to toxins effects in various kinds of skin disorders. Skin disease is one of the leading causes of non-fatal disease burden globally, affecting millions of people.